Submitted by marketwatch5869 in business
Drugmaker reaffirms full-year 2024 guidance, ducks questions on experimental obesity drug
Submitted by marketwatch5869 in business
Drugmaker reaffirms full-year 2024 guidance, ducks questions on experimental obesity drug